Events, news, and information for the people who influence the business strategies of the life science industry.

MediSieve's CEO explains magnetic blood filtration at Xcelerate Startup Pitch Competition

Share this article

George Frodsham, CEO at MediSieve, won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by EBD Group and Xcelerate Insight during Biotech Week Boston in September, 2018. With the ability to specifically and selectively remove disease-causing agents from the blood, MediSieve’s magnetic blood filtration has the potential to transform the treatment of blood borne diseases such as sepsis, leukemia and malaria. The pitch competition is designed to give early stage companies exposure to possible investors and partners, and is judged by top venture capitalists and industry experts.

Share this article

Upcoming event

BIO-Europe Spring

23 - 27 Mar 2020, Now delivered digitally
Thank you for attending BIO-Europe Spring - delivered digitally
Go to site